Freenome is a biotechnology company that develops blood tests to detect early-stage cancer. The company uses artificial intelligence and genomics to analyze blood samples and identify cancerous cells. Freenome's mission is to empower doctors to detect cancer early, when it is most treatable, and ultimately save lives. The company was founded in 2014 and is headquartered in San Francisco, California.